A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Nabilone (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 28 Aug 2012 Results presented at the 14th World Congress on Pain.
- 08 May 2012 Status changed from recruiting to completed.
- 28 Apr 2012 Results presented at the 64th Annual Meeting of the American Academy of Neurology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History